These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 29338294)
21. Toxic Epidermal Necrolysis Related to Paliperidone Palmitate: First Case Report. Struye A; Depuydt C; Abdel Sater E; Dubois V J Clin Psychopharmacol; 2016 Jun; 36(3):279-82. PubMed ID: 26928057 [No Abstract] [Full Text] [Related]
22. [Prevention and treatment of tardive dyskinesia caused by antipsychotic drugs]. Seigneurie AS; Sauvanaud F; Limosin F Encephale; 2016 Jun; 42(3):248-54. PubMed ID: 26922134 [TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics, safety, and tolerability of paliperidone palmitate 3-month formulation in patients with schizophrenia: A phase-1, single-dose, randomized, open-label study. Ravenstijn P; Remmerie B; Savitz A; Samtani MN; Nuamah I; Chang CT; De Meulder M; Hough D; Gopal S J Clin Pharmacol; 2016 Mar; 56(3):330-9. PubMed ID: 26189570 [TBL] [Abstract][Full Text] [Related]
24. Tardive dyskinesia induced by a switch from haloperidol depot to paliperidone palmitate. Hsu CY; Lin YH; Shen YC J Neuropsychiatry Clin Neurosci; 2013; 25(4):E46-7. PubMed ID: 24247889 [No Abstract] [Full Text] [Related]
25. Case Report: Paliperidone Palmitate, But Not Aripiprazole, as a Possible Risk Factor for Pulmonary Embolism. Michaud I; Landry P J Clin Psychopharmacol; 2018 Aug; 38(4):392-394. PubMed ID: 29746335 [No Abstract] [Full Text] [Related]
26. Paliperidone induced neutropenia in first episode psychosis: a case report. Martos N; Hall W; Marhefka A; Sedlak TW; Nucifora FC BMC Psychiatry; 2021 Feb; 21(1):76. PubMed ID: 33549083 [TBL] [Abstract][Full Text] [Related]
27. Paliperidone for the treatment of schizophrenia and schizoaffective disorders - a drug safety evaluation. Mauri MC; Reggiori A; Paletta S; Di Pace C; Altamura AC Expert Opin Drug Saf; 2017 Mar; 16(3):365-379. PubMed ID: 28140680 [TBL] [Abstract][Full Text] [Related]
28. Tardive Tourette-like syndrome in a patient treated with paliperidone. Fountoulakis KN; Panagiotidis P J Neuropsychiatry Clin Neurosci; 2011; 23(4):E35-6. PubMed ID: 22231343 [No Abstract] [Full Text] [Related]
34. Pharmacokinetic drug evaluation of paliperidone in the treatment of schizoaffective disorder. Macaluso M; Oliver H; Sohail Z Expert Opin Drug Metab Toxicol; 2017 Aug; 13(8):871-879. PubMed ID: 28675307 [TBL] [Abstract][Full Text] [Related]
35. Paliperidone-induced rhabdomyolysis: a case report. Fernández-Macho JG; Espárrago-Llorca G; Morales-Gómez GR; Guisado-Macías JA Actas Esp Psiquiatr; 2015; 43(2):66-8. PubMed ID: 25812544 [No Abstract] [Full Text] [Related]